Sharon Ayd, PhD, MBA is a Biopharmaceutical industry veteran with 30+ years of industry experience in all phases of drug development and has been instrumental in obtaining FDA approval for numerous drug applications. She is currently an adjunct professor in Master of Science in Law Program at Northwestern and previously served as Global Vice President of Research and Development at Fresenius Kabi USA, where she turned around operational performance of the Innovation & Development Center.
She has also served as Chief Scientific Officer at Pinnacle Biologics, Inc., where she repurposed and revitalized an orphan-designated pipeline of oncology drugs.